Upcoming Neuromodulation Event
In person
November 1-2, 2024 | New York, NY
Mount Sinai BioDesign is excited to introduce the inaugural New York Brain Computer Interface (NY-BCI) Symposium this Fall in NYC. Join us as we explore the future of neural interfaces at the New York Academy of Medicine. With a focus on surgical and clinical translation strategies, this worldwide symposium will be the first-of-its-kind in setting the standard for BCI translation, implementation, and commercialization. The event will be hosted by a mix of leading startups (including Synchron and Precision Neuroscience) clinical institutional partners (including Mount Sinai, UPMC, CMU), federal regulatory organizations, and patient advocacy leaders. Keynotes, panels, and breakout sessions will be led by the world’s leading scientific, surgical, industry, and regulatory experts.
| Time | Session |
|---|---|
| November 1, 2024 | |
| 1:00-1:30 PM | Registration / Breakfast |
| 1:30-1:40 PM | Welcome Remarks Joshua Bederson, MD System Chair, The Leonard I. Malis, MD and Corinne and Joseph Graber Professor of Neurosurgery Icahn School of Medicine at Mount Sinai, Mount Sinai Health System |
| 1:40-2:30 PM | The Evolution & Future of Invasive BCI Douglas Weber, PhD Akhtar and Bhutta Endowed Professor, Department of Mechanical Engineering and the Neuroscience Institute Carnegie Mellon University |
| 2:30-3:10 PM | Current State of Clinical Trials Daniel Rubin, MD, PhD Assistant Professor of Neurology Harvard Medical School / Massachusetts General Hospital |
| 3:10-3:50 PM | Patient Need for Implantable BCI Mariska J. Vansteensel, PhD UMC Utrecht Brain Center, Department of Neurosurgery UMC Utrecht, The Netherlands |
| Break / Refreshments (20 mins) | |
| 4:10-4:50 PM | Modern BCI in Neurological Recovery David Putrino, PhD Professor, Department of Rehabilitation and Human Performance Icahn School of Medicine at Mount Sinai Christopher Kellner, MD Associate Professor of Neurosurgery Icahn School of Medicine at Mount Sinai |
| 4:50-5:30 PM | Funding & Investment Landscape for Implantable BCI Startups Alex Morgan, MD, PhD Partner, Khosla Ventures |
| 5:30-6:00 PM | Patient Story Ian Burkhart Founder, BCI Pioneers Coalition President, North American Spinal Cord Consortium (NASCIC) |
| 6:10-7:10 PM | NeuroTech Networking - Cocktail Reception |
| 7:30-10:00 PM | Speaker & Sponsor Dinner |
| November 2, 2024 | |
| 8:00-8:50 AM | Registration / Breakfast |
| 8:50-9:00 AM | Welcome Remarks Joshua Bederson, MD System Chair, The Leonard I. Malis, MD and Corinne and Joseph Graber Professor of Neurosurgery Icahn School of Medicine at Mount Sinai, Mount Sinai Health System |
| 9:00-9:30 AM | Optimizing & Defining BCI Trial Outcomes Abbey Sawyer, PhD Postdoctoral Research Fellow, Abilities Research Center, Department of Rehabilitation & Human Performance Icahn School of Medicine at Mount Sinai |
| 9:30-10:00 AM | The Intersection of Surgical Specialty & Implantable BCI |
| Break / Refreshments (10 mins) | |
| 10:20-11:10 AM | Advancements in BCI Engineering & Electronics Robert Gaunt, PhD Associate Professor of Physical Medicine and Rehabilitation, University of Pittsburgh Engineering Director, Neural Engineering Labs Noam Harel, MD, PhD Associate Professor of Neurology, Icahn School of Medicine at Mount Sinai |
| 11:10-12:30 PM | BCI Startup Spotlight Max Hodak, CEO, Science Florian Solzbacher, PhD Gerald and Barbara Stringfellow Endowed Professor, University of Utah Co-Founder, Director and CSO, Blackrock Neurotech Peter Yoo, PhD Senior Director, Neuroscience & Algorithms, Synchron |
| 12:30-1:10 PM | Lunch Meet the Experts |
| 1:10-1:50 PM | I Lived the Experience: The Challenges of Removal & Replacement Ian Burkhart Founder, BCI Pioneers Coalition President, North American Spinal Cord Consortium (NASCIC) Nita Farahany Robinson O. Everett Distinguished Professor of Law and Professor of Philosophy, Duke University School of Law J Mocco, MD, MS Senior System Vice Chair and The Kalmon D. Post, MD Professor of Neurosurgery, Icahn School of Medicine at Mount Sinai Benjamin Rapoport, MD, PhD Chief Science Officer & Co-Founder, Precision Neuroscience |
| 1:50-2:30 PM | Active Clinical Trials of BCI: How to Select the Right Patient for the Right Trial Riki Banerjee, PhD Chief Technology Officer, Synchron |
| Break / Refreshments (20 mins) | |
| 2:50-3:20 PM | Supporting a Product from Bench to Clinical Usage in a Patient's Home Benjamin Rapoport, MD, PhD Chief Science Officer & Co-Founder, Precision Neuroscience Thomas Oxley, MD, PhD CEO, Synchron and Director of Innovation, Mount Sinai BioDesign, Synchron |
| 3:30-4:10 PM | Bringing BCI to Patients: The Pathway Forward David McMullen, MD Office Director, OHT5: Office of Neurological and Physical Medicine Devices Center for Devices and Radiological Health, U.S. Food and Drug Administration |
| 4:10-4:30 PM | Conference Closing Remarks Joshua Bederson, MD System Chair, The Leonard I. Malis, MD and Corinne and Joseph Graber Professor of Neurosurgery Icahn School of Medicine at Mount Sinai, Mount Sinai Health System |
Comprehensive listing of Brain Stimulation events, conferences, workshops, and webinars.